⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19726737 | 1.00 | — | — | |
| SCHEMBL10000086 | 1.00 | — | — | |
| SCHEMBL15492694 | 0.87 | — | — | |
| SCHEMBL12254993 | 0.86 | — | — | |
| SCHEMBL22256504 | 0.86 | — | — | |
| SCHEMBL12306873 | 0.86 | — | — | |
| SCHEMBL24869814 | 0.86 | — | — | |
| SCHEMBL16921641 | 0.86 | — | — | |
| SCHEMBL19912249 | 0.86 | — | — | |
| SCHEMBL15281151 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240026421-A1 | METHODS FOR CAPTURING LONG POLYNUCLEOTIDES FOR SEQUENCING SPECIFIC GENOMIC REGIONS | GENERATION BIOTECH, LLC (US) | 2024-01-25 | — | — | US | disclosed |
| US-11821023-B2 | Method for capturing long polynucleotides for sequencing specific gnomic regions | GENERATION BIOTECH, LLC (US) | 2023-11-21 | — | — | US | disclosed |
| US-11795459-B2 | Targeted inhibition using engineered oligonucleotides | MIRECULE, INC. (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230287418-A1 | MODIFIED SIRNA WITH REDUCED OFF-TARGET ACTIVITY | TUOJIE BIOTECH(SHANGHAI) CO., LTD. (CN) | 2023-09-14 | — | — | US | disclosed |
| US-20140057252-A1 | Binary DNA Probe for Fluorescent Analysis of Nucleic Acids | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2014-02-27 | — | — | US | disclosed |
| US-20120156138-A1 | Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming | SMITH LARRY J (US) | 2012-06-21 | — | — | US | disclosed |